Global Meningococcal Vaccines Market Expected to Grow at a Healthy Pace During 2024-2032, Driven by the Growing Public Health Awareness

The market for meningococcal vaccines is being driven by the growing public health awareness and initiatives undertaken by the government to help safeguard children of various age-groups from getting infected by meningococcal disease. The market is further aided by the rising number of individuals becoming conscious regarding the symptoms, and the effect of meningococcal meningitis and its subsequent treatment options, especially in the worst-hit regions. Moreover, the rising access to meningococcal vaccines in the developing regions, like in some African countries, by the support of global organisations, which have been helping with the vaccine prequalification, procurement, and funding, is facilitating the market growth of meningococcal vaccines.

The rising competition among the industry key players like Pfizer Inc. (NYSE: PFE) and Sanofi SA is providing impetus to the market growth. In June 2020, Pfizer Inc. announced the beginning of four phase 3 clinical trials for investigational vaccines, including the pentavalent meningococcal vaccine candidate, MenABCWY, in both adolescents and young adults to determine the safety, tolerability, and immunogenicity of MenABCWY vaccine candidate, in comparison to the licensed meningococcal vaccines. This will help determine the immunologic noninferiority of the candidate. Such ongoing research and development in the pharmaceutical industry are expected to stimulate the market growth over the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Type, Age Group, Distribution Channel, and Region:

• The meningococcal vaccines industry, on the basis of type, is divided into polysaccharide vaccine (MPSV4), conjugate vaccine (MCV4), and serogroup B vaccine (MenB-FHpb/MenB-4C).

• Based on age group, the industry is segmented into infants, children, and adults, among others.

• On the basis of distribution channel, the industry is categorised into institutional sales and retail sales.

• Regionally, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for meningococcal vaccines is being driven by the growing initiatives like National Immunization Programs (NIPs) by the government with the support of private non-profit organisations for the formation of meningococcal vaccines.

• In addition to this, the inclusion of this disease in the National Immunization Programs (NIPs) is further promoting the affordability and sustainability of the vaccine supply, further aiding the market growth.

• Moreover, the abundance of opportunities for the manufacturers within this industry is propelling the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for meningococcal vaccines for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the types, age groups, distribution channels, and major regions of meningococcal vaccines.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, and Incepta Vaccine Ltd., among others, are the key players in the global meningococcal vaccines market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790